The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin‐Norepinephrine Reuptake Inhibitors: American Headache Society Position PaperRandolph W. Evans, Gretchen E. Tietjen, Robert E. Shapiro et al.|Headache The Journal of Head and Face Pain|2010Cited by 126
Triptans and Serotonin Syndrome – A ResponseStewart J. Tepper, Gretchen E. Tietjen, Robert E. Shapiro et al.|Headache The Journal of Head and Face Pain|2012Cited by 2